Sun Pharmaceutical Industries Share Price Today - Live Blog for November 12, 2025

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.10% slump and is currently trading at ₹1,730.00. While the stock maintains a PE ratio of 39.2700, the industry PE is 33.7264, raising questions about valuation.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.10% drop, and it's now trading at ₹1,730.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.03% in its share price, and it currently trades at ₹1,732.75 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.10% increase. Presently, it is actively trading at ₹1,732.55.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.06% surge in its share price and is presently trading at ₹1,730.20, captivating the attention of market participants.

After a notable 0.13% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,731.15. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

With a -0.15% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,728.95. Investors should examine the factors driving this decline. The stock's PE ratio is 39.2700, whereas the industry PE ratio stands at 33.7264.

Following a noteworthy 0.05% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,731.60. When it comes to valuation, this stock has a PE ratio of 39.2700, with the industry PE ratio at 33.7264.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.04% decline, and it currently trades at ₹1,730.80 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

After a notable 0.07% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,731.45. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

After a -0.14% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,730.70. The stock has a PE ratio of 39.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

After a -0.45% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,732.50. The stock has a PE ratio of 39.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Following a noteworthy 0.13% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,742.40. When it comes to valuation, this stock has a PE ratio of 39.2700, with the industry PE ratio at 33.7264.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.27%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,740.00 per share.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.07% increase and currently trading at ₹1,735.30 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd experienced a -0.05% dip in its share price and is currently trading at ₹1,734.10. The stock has a PE ratio of 39.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.06%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,735.00 per share.

Sun Pharmaceutical Industries Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,733.90. The stock has a PE ratio of 39.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.11% surge in its share price and is presently trading at ₹1,736.45, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.11%, and as of now, it's trading at ₹1,736.45 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.14%, reaching a current market price of ₹1,735.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.36% uptick in its share price. As a result, it's now actively trading at ₹1,737.75 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.37%, reaching the current market value of ₹1,732.00 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.07% surge in its share price and is presently trading at ₹1,717.45. The increased investor interest is driving this surge.

With a -0.02% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,716.25. The stock is currently trading at a PE of 39.2700, while the industry PE is 33.7264, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.33%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,714.65, and market participants are assessing the implications. The stock has a PE ratio of 39.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.35% decline, and it currently trades at ₹1,721.90 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.